Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib. [electronic resource]
Producer: 20120113Description: e819-22 p. digitalISSN:- 1527-7755
- Aged
- Antineoplastic Agents -- therapeutic use
- Base Sequence
- Carcinoma, Large Cell -- drug therapy
- Carcinoma, Neuroendocrine -- drug therapy
- Female
- Gefitinib
- Genes, erbB-1
- Humans
- Lung Neoplasms -- drug therapy
- Molecular Sequence Data
- Mutation
- Neoplasm Metastasis
- Protein Kinase Inhibitors -- therapeutic use
- Quinazolines -- therapeutic use
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.